Biomarker Driven Treatment of Selected NSCLC: EGFR. EGFR TKI in Mutant EGFR NSCLC. Mechanisms of Resistance and New Generation EGFR TKI.

Event ESMO Preceptorship on NSCLC Singapore December 2016
Session Session 4 Biomarker Driven Treatment
Topics Non-Small-Cell Lung Cancer, Metastatic
Biomarkers
Presenter J. Bennouna, FR